Publicacións en colaboración con investigadores/as de Universidad Autónoma de Madrid (9)

2024

  1. Evaluation of the transition from intravenous to subcutaneous vedolizumab in patients with inflammatory bowel disease

    Gastroenterologia y Hepatologia

  2. Intensification with Intravenous Ustekinumab in Refractory Crohn’s Disease

    Journal of Clinical Medicine, Vol. 13, Núm. 3

  3. Selective granulocyte–monocyte apheresis during induction with vedolizumab in moderate–severe ulcerative colitis: Experience in a tertiary hospital

    Gastroenterologia y Hepatologia, Vol. 47, Núm. 7, pp. 721-726

2023

  1. I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease

    Clinical Gastroenterology and Hepatology, Vol. 21, Núm. 3, pp. 771-788.e10

  2. Influence of biologic therapy on cardiovascular risk factors in patients with inflammatory bowel disease

    Gastroenterologia y Hepatologia, Vol. 46, Núm. 2, pp. 109-115

  3. Randomized clinical trial evaluating three low-volume preparations for colonoscopy in outpatients with Inflammatory Bowel Disease: the EII-PREP trial

    Scandinavian Journal of Gastroenterology, Vol. 58, Núm. 6, pp. 656-663

  4. Seroprevalence of ANTI-SARS-CoV-2 antibodies in patients with inflammatory bowel disease

    Scientific Reports, Vol. 13, Núm. 1

2021

  1. Doppler Activity and Ultrasonographic Detection of Intra-Abdominal Fistulas Are Predictors of Surgery in Crohn's Disease

    Digestive Diseases, Vol. 39, Núm. 3, pp. 204-210

2019

  1. Double-strand break repair through homologous recombination in autosomal-recessive BCL10 deficiency

    Journal of Allergy and Clinical Immunology, Vol. 143, Núm. 5, pp. 1931-1934.e1